乳房影像市場中的人工智慧 - 全球產業規模、佔有率、趨勢、機會和預測，按組件、按成像方式、按應用、按最終用途、按地區和競爭進行細分，2020-2030 年

2024 年全球乳房影像市場人工智慧價值為 3.2032 億美元，預計到 2030 年將達到 4.4198 億美元，預測期內複合年成長率為 5.47%。受對早期和準確乳癌檢測的需求不斷成長的推動，全球乳房影像人工智慧市場正在經歷顯著成長。人工智慧技術，尤其是深度學習演算法，正在透過改進影像分析、減少人為錯誤和提高診斷速度來徹底改變診斷過程。這些進步使得人們能夠更精確地檢測腫瘤和異常，進而帶來更好的患者治療效果。乳癌發生率的不斷上升以及數位影像技術的普及推動了市場的發展。人工智慧與乳房X光照射和超音波等其他醫學影像方式的結合進一步增強了市場潛力。隨著醫療保健系統越來越重視個人化和高效的護理，人工智慧在乳房影像中的作用預計將持續成長。

主要市場促進因素

乳癌發生率上升

主要市場挑戰

資料隱私和安全問題

主要市場趨勢

早期檢測和篩檢的需求不斷成長

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球乳房影像人工智慧市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按組件（硬體和軟體）
  • 依影像方式（乳房 X 光攝影、超音波影像和 MRI）
  • 按應用（篩檢、診斷和影像引導活體組織切片）
  • 依最終用途（醫院和診所、診斷影像中心和研究機構）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第 6 章：北美乳房影像人工智慧市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第 7 章：歐洲乳房影像人工智慧市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太地區乳房影像人工智慧市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲乳房影像人工智慧市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲乳房影像人工智慧市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如果有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Visage Imaging, Inc.
• CureMetrix, Inc.
• DeepHealth, Inc.
• GE HealthCare Technologies Inc.
• Hologic, Inc.
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Koninklijke Philips NV
• iCAD, Inc.
• Medicalgorithmics SA

第 15 章：策略建議

第16章 關於出版商,免責事項

Global AI in Breast Imaging Market was valued at USD 320.32 Million in 2024 and is expected to reach USD 441.98 Million by 2030 with a CAGR of 5.47% during the forecast period. The global AI in breast imaging market is experiencing significant growth, driven by the increasing demand for early and accurate breast cancer detection. AI technologies, particularly deep learning algorithms, are revolutionizing the diagnostic process by improving image analysis, reducing human error, and enhancing the speed of diagnosis. These advancements allow for more precise detection of tumors and abnormalities, leading to better patient outcomes. The growing prevalence of breast cancer, along with the rise in the adoption of digital imaging technologies, is contributing to the market's expansion. The integration of AI with other medical imaging modalities, such as mammography and ultrasound, further enhances the market potential. As healthcare systems increasingly prioritize personalized and efficient care, AI's role in breast imaging is expected to continue growing.

Key Market Drivers

Increasing Incidence of Breast Cancer

Breast cancer continues to be one of the most prevalent types of cancer worldwide, with millions of new cases diagnosed annually. The rising incidence of breast cancer is primarily attributed to lifestyle changes, aging populations, and environmental factors. According to the American Cancer Society, breast cancer is the second leading cause of cancer deaths among women in the United States. As the incidence of breast cancer increases, so does the need for improved diagnostic methods to detect the disease at the earliest possible stage. Early detection is critical for improving prognosis, as it allows for more effective treatment options and a higher chance of survival. According to WHO, in 2022, breast cancer led to approximately 670,000 deaths worldwide. Around half of all breast cancer cases occur in women with no distinct risk factors other than their sex and age. It was the most common cancer among women in 157 out of 185 countries that year. Breast cancer affects individuals globally, with occurrences in every country. While predominantly a women's disease, about 0.5-1% of breast cancer cases are found in men.

Key Market Challenges

Data Privacy and Security Concerns

As with any technology that deals with sensitive healthcare data, AI in breast imaging faces significant challenges related to data privacy and security. Breast imaging datasets often contain highly personal medical information, and the need to protect this data from unauthorized access or breaches is paramount. Healthcare providers, hospitals, and tech companies developing AI tools must ensure compliance with stringent data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, the General Data Protection Regulation (GDPR) in Europe, and other regional laws.

Key Market Trends

Growing Demand for Early Detection and Screening

The global healthcare industry is increasingly prioritizing early detection, and breast cancer screening is no exception. The earlier breast cancer is detected, the higher the likelihood of successful treatment and improved survival rates. Consequently, early detection technologies are a significant focus for healthcare systems worldwide. Routine screenings, such as mammograms, are now widely recommended for women above a certain age or those with higher risk factors, such as family history or genetic predispositions. Early screening not only helps identify cancer in its most treatable stages but also lowers overall healthcare costs by preventing the need for more aggressive treatments that are required for late-stage cancers.

All leading medical organizations in the US recommend screening mammography for women aged 40 and above. Studies have shown that screening mammography reduces breast cancer mortality by approximately 20% to 35% in women aged 50 to 69, and by a slightly lower percentage in women aged 40 to 49, with a 14-year follow-up. Despite the effectiveness of mammograms and other imaging techniques, there are challenges in detecting early-stage tumors, particularly in women with dense breast tissue, where mammograms are less sensitive. AI-powered tools can help overcome this limitation by improving image clarity, identifying cancerous areas more accurately, and providing additional insights to clinicians. AI algorithms are trained to detect early-stage cancers that might be missed in a routine manual review of mammograms, reducing the risk of false negatives.

Key Market Players

• Visage Imaging, Inc.
• CureMetrix, Inc.
• DeepHealth, Inc.
• GE HealthCare Technologies Inc.
• Hologic, Inc.
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Koninklijke Philips N.V.
• iCAD, Inc.
• Medicalgorithmics SA

Report Scope:

In this report, the Global AI In Breast Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI In Breast Imaging Market, By Component:

• Hardware
• Software

AI In Breast Imaging Market, By Imaging Modality:

• Mammography
• Ultrasound Imaging
• MRI

AI In Breast Imaging Market, By Application:

• Screening
• Diagnostics
• Image-guided Biopsy

AI In Breast Imaging Market, By End Use:

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Research Institutes

AI In Breast Imaging Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI In Breast Imaging Market.

Available Customizations:

Global AI In Breast Imaging market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI In Breast Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Hardware and Software)
  • 5.2.2. By Imaging Modality (Mammography, Ultrasound Imaging, and MRI)
  • 5.2.3. By Application (Screening, Diagnostics, and Image-guided Biopsy)
  • 5.2.4. By End Use (Hospitals & Clinics, Diagnostic Imaging Centers, and Research Institutes)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America AI In Breast Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Imaging Modality
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States AI In Breast Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Imaging Modality
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada AI In Breast Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Imaging Modality
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico AI In Breast Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Imaging Modality
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe AI In Breast Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Imaging Modality
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany AI In Breast Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Imaging Modality
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. United Kingdom AI In Breast Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Imaging Modality
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. Italy AI In Breast Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Imaging Modality
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. France AI In Breast Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Imaging Modality
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain AI In Breast Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Imaging Modality
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia-Pacific AI In Breast Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Imaging Modality
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China AI In Breast Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Imaging Modality
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India AI In Breast Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Imaging Modality
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan AI In Breast Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Imaging Modality
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea AI In Breast Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Imaging Modality
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia AI In Breast Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Imaging Modality
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. South America AI In Breast Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Imaging Modality
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil AI In Breast Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Imaging Modality
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina AI In Breast Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Imaging Modality
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia AI In Breast Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Imaging Modality
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. Middle East and Africa AI In Breast Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Imaging Modality
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa AI In Breast Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Imaging Modality
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia AI In Breast Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Imaging Modality
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE AI In Breast Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Imaging Modality
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Visage Imaging, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. CureMetrix, Inc.
• 14.3. DeepHealth, Inc.
• 14.4. GE HealthCare Technologies Inc.
• 14.5. Hologic, Inc.
• 14.6. Siemens Healthineers AG
• 14.7. Fujifilm Holdings Corporation
• 14.8. Koninklijke Philips N.V.
• 14.9. iCAD, Inc.
• 14.10. Medicalgorithmics SA

15. Strategic Recommendations

16. About Us & Disclaimer